Publications by authors named "Keith Frank"

Claim this Profile
E
Early Experience of an Aviation Peer Support Program in the US Air Force to Drive Readiness and Address Healthcare Avoidance.
William R Hoffman, Darrell Zaugg, Gerhard Fahnenbruck, Aedrian Bekker, Keith Frank

Mil Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I evaluation of CycloSam (Sm-153-DOTMP) bone seeking radiopharmaceutical in dogs with spontaneous appendicular osteosarcoma.
Kim A Selting, Jaime Simon, Jim C Lattimer, Alan Ketring, Sandra Axiak-Bechtel, Keith Frank

Vet Radiol Ultrasound· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric implications of the potential radionuclidic impurities in Sm-DOTMP.
Richard E Wendt, Alan R Ketring, R Keith Frank, Jaime Simón

Appl Radiat Isot· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dental radiation dosimetric maps from intensity-modulated radiation therapy planning for head and neck cancers.
Simran Polce, Emile Gogineni, Jeffrey Antone, Maged Ghaly, Douglas Keith Frank

Head Neck· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional analysis of a conserved domain in SWITCH1 reveals a role in commitment to female meiocyte differentiation in Arabidopsis.
Survi Mahesh, Kaladhar Bethoju, Aswan Nalli, Keith Frank, Imran Siddiqi

Biochem Biophys Res Commun· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All's Not Well(ens) that Ends Well: Case Study of Significant Thebesian Veins Mimicking Wellens Syndrome.
Keith Frank

Spartan Med Res J· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetry of a (90)Y-hydroxide liquid brachytherapy treatment approach to canine osteosarcoma using PET/CT.
Jien Jie Zhou, Arnulfo Gonzalez, Mark W Lenox, Theresa W Fossum, R Keith Frank

Appl Radiat Isot· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical.
Jaime Simón, R Keith Frank, Druce K Crump, William D Erwin, Naoto T Ueno

Nucl Med Biol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177Lu.
Huma Mohsin, Fang Jia, Jeffrey N Bryan, Geethapriya Sivaguru, Cathy S Cutler, R Keith Frank

Bioconjug Chem· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3.
Huma Mohsin, Jonathan Fitzsimmons, Tiffani Shelton, Timothy J Hoffman, Cathy S Cutler, R Keith Frank

Nucl Med Biol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu.
Huma Mohsin, Fang Jia, Geethapriya Sivaguru, Michael J Hudson, Tiffani D Shelton, R Keith Frank

Bioconjug Chem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of 225Ac radioimmunopharmaceuticals.
Michael R McDevitt, Dangshe Ma, Jim Simon, R Keith Frank, David A Scheinberg

Appl Radiat Isot· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis